BioStem Technologies, Inc.
General ticker "BSEM" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $70.9M (TTM average)
BioStem Technologies, Inc. does not follow the US Stock Market performance with the rate: -24.2%.
Estimated limits based on current volatility of 7.3%: low 1.04$, high 1.20$
Factors to consider:
- Earnings expected soon, date: 2026-11-12 amc
- Current price 51.7% below estimated low
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [2.32$, 6.19$]
- 2026-12-31 to 2027-12-31 estimated range: [2.12$, 5.31$]
Financial Metrics affecting the BSEM estimates:
- Positive: with PPE of -7.7 at the end of fiscal year the price was low
- Positive: 15.26 < Operating cash flow per share per price, % of 15.38
- Positive: -17.75 < Operating profit margin, % of -1.43
- Positive: -4.02 < Investing cash flow per share per price, % of -3.25
- Positive: Interest expense per share per price, % of 0 <= 0
Short-term BSEM quotes
Long-term BSEM plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $16.69MM | $301.83MM | $47.48MM |
| Operating Expenses | $24.46MM | $270.63MM | $48.17MM |
| Operating Income | $-7.78MM | $31.20MM | $-0.69MM |
| Non-Operating Income | $-0.70MM | $-0.59MM | $0.30MM |
| Interest Expense | $0.70MM | $0.59MM | $0.00MM |
| R&D Expense | $0.34MM | $1.91MM | $7.09MM |
| Income(Loss) | $-8.48MM | $30.61MM | $-0.39MM |
| Taxes | $0.00MM | $-1.27MM | $6.19MM |
| Net Income(Loss)* | $-8.48MM | $31.88MM | $-6.58MM |
| Stockholders Equity | $-1.34MM | $40.88MM | $39.14MM |
| Inventory | $0.66MM | $1.82MM | $2.88MM |
| Assets | $14.56MM | $140.38MM | $50.03MM |
| Operating Cash Flow | $-3.50MM | $24.48MM | $9.94MM |
| Capital expenditure | $0.21MM | $0.43MM | $3.35MM |
| Investing Cash Flow | $-0.21MM | $-1.68MM | $-2.10MM |
| Financing Cash Flow | $3.18MM | $-0.21MM | $-1.12MM |
| Earnings Per Share** | $-0.62 | $1.95 | $-0.39 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.